Blue Crest Capital Management LTD Magenta Therapeutics, Inc. Call Options Transaction History
Blue Crest Capital Management LTD
- $1.62 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MGTA
# of Institutions
2Shares Held
442KCall Options Held
0Put Options Held
0About Magenta Therapeutics, Inc.
- Ticker MGTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,890,500
- Description
- Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...